Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11528 posts found.

Reforms raise conflicts of interest, say GPs

October 25, 2011 Sales and Marketing BMA, NHS, NHS reforms

Two-thirds of doctors believe that the government’s health reforms will create conflicts of interests in their jobs and undermine their …
News

David Meeker appointed as chief executive of Genzyme

October 25, 2011 Research and Development, Sales and Marketing Genzyme, Sanofi

Sanofi has appointed David Meeker as chief executive of its new biotech acquisition Genzyme. He will report to Christopher Viehbacher, …
Appointment
Sanofi HQ

Sanofi’s Lemtrada beats Rebif in MS study

October 25, 2011 Research and Development, Sales and Marketing Lemtrada, Sanofi

Sanofi’s investigational multiple sclerosis drug Lemtrada has beaten Rebif in a late-stage trial. The Phase III results show that 78% …
News

Risk Based Inspections for good pharmacovigilance practice

October 24, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Recently in the UK there has been a move towards risk-based inspection programmes.  The scope, frequency and depth of MHRA …
News
Press release
Lab image

Does drug development deliver on its promises?

October 24, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Les Rose, R&D

I am always guided by the motto of the Royal Society, ‘Nullius in Verba’. This means, with typical Latin brevity: …
Feature

Bristol-Myers Squibb makes three senior management changes

October 24, 2011 Medical Communications, Research and Development, Sales and Marketing BMS

BMS has made three changes to its senior management with Giovanni Caforio promoted to president of US pharmaceuticals and Charles …
Appointment
Depakote

Abbott to pay $1.3 billion for Depakote lawsuits

October 24, 2011 Research and Development, Sales and Marketing Abbott, Depakote

 
News

Merck Serono returns Parkinson’s drug rights to Newron

October 24, 2011 Research and Development, Sales and Marketing Merck Serono, Newron

Merck Serono has returned the rights to the Parkinson’s disease drug safinamide back to Newron. The decision comes after the …
News

Number of CCGs continues to shrink

October 23, 2011 Sales and Marketing CCG, CCGs, NHS reform, clinical commissioning, primary care

The number of regional groups preparing to take over control of the NHS in England is rapidly shrinking, as the …
News

Abbott spin-off could attract mega merger

October 21, 2011 Research and Development, Sales and Marketing Abbott, Bayer, Humira, Merck, Roche

Abbott’s new spin-off pharma firm could attract a lot of attention from big pharma looking to sure up their portfolios. …
News
Abbott

Abbott to split into two separate companies

October 20, 2011 Manufacturing and Production, Research and Development, Sales and Marketing Abbott, Abbott Laboratories

Abbott’s management has decided to split the company into two separate entities in order to give shareholders a ‘distinct investment …
News
GSK

Rumours abound on GSK-HGS takeover bid

October 20, 2011 Research and Development, Sales and Marketing Benlysta, GSK, HGS

Rumours are gathering pace that GlaxoSmithKline may launch a takeover bid for struggling US firm Human Genome Sciences. British tabloid …
News
Herceptin image

Injectable Herceptin proves its worth

October 20, 2011 Research and Development, Sales and Marketing Herceptin, Roche

An injectable version of Roche’s breast cancer drug Herceptin compares favourably to the standard intravenous infusion, according to new research. …
News

Medical Devices: Harmonisation of Requirements for Address of Manufacturer

October 19, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The inclusion of the manufacturer’s address on the labels and instructions for use is an Essential Requirement according to the …
News
Press release

Opportunity to Realise the Value of Dormant UK Authorisations before December Deadline

October 19, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Holders wishing to cancel their authorisations, registrations and licences are required to notify the MHRA by 31 December 2011 to …
News
Press release
The Gateway to Local Adoption Series

Latest content

NICE recommends daratumumab quadruplet for newly diagnosed multiple myeloma

October 8, 2026

AstraZeneca’s Trixeo approved in EU for asthma

October 8, 2026

Amplio reports early human data for novel methotrexate approach in rheumatoid arthritis

October 7, 2026

Survodutide delivers up to 13.1% weight loss in phase 3 obesity and diabetes trial

October 6, 2026

ESTEVE CDMO adds $17.5m to Illinois expansion

October 6, 2026